Recombinant leukocyte interferon, doxorubicin, and 5FUDR in patients with hepatocellular carcinoma-A phase II trial

Lynn G. Feun, Christopher O'Brien, Enrique Molina, Miguel Rodriguez, Lenox Jeffers, Eugene R. Schiff, Angela Marini, Niramol Savaraj, Bach Ardalan

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Fingerprint Dive into the research topics of 'Recombinant leukocyte interferon, doxorubicin, and 5FUDR in patients with hepatocellular carcinoma-A phase II trial'. Together they form a unique fingerprint.

Medicine & Life Sciences